Gaxos.AI Shares Soar Following AI Platform Expansion and Strategic Partnerships

Gaxos.AI Shares Soar Following AI Platform Expansion and Strategic Partnerships

Gaxos.AI (NASDAQ: GXAI) witnessed a significant after-hours stock surge of over 19% on Thursday. This upward movement followed the company's announcement of an expanded Gaxos Labs platform, integrating new AI Music Generation, AI Chat, and AI 3D Model Creation tools. The strategic enhancement aims to boost user engagement and solidify its position in the rapidly evolving generative AI market. Additionally, a partnership with BytePlus to enhance AI video tools further underpins Gaxos.AI's growth trajectory.

By Vicki Robin
Finance

Finance

View more
News

News

View more
Middle East Ceasefire: Progress and Persistent Challenges in Iran-Israel-Lebanon Conflict

Middle East Ceasefire: Progress and Persistent Challenges in Iran-Israel-Lebanon Conflict

A 10-day ceasefire has been implemented between Israel and Lebanon, sparking hope for a lasting peace agreement. US President Donald Trump believes a resolution to the conflict with Iran is imminent. However, despite diplomatic progress, significant obstacles, including Hezbollah's disarmament and Israel's security concerns, continue to impede a comprehensive and permanent peace in the region.

By Mona Chalabi
Former Coast Guard Doctor Nominated as CDC Director Amidst Agency Turmoil

Former Coast Guard Doctor Nominated as CDC Director Amidst Agency Turmoil

President Trump has put forth Dr. Erica Schwartz, a former deputy surgeon general and decorated military physician, as his choice to lead the Centers for Disease Control and Prevention. This nomination comes as the CDC has been operating without a permanent director for much of Trump's second term, and the agency faces internal challenges and significant budget reductions. Dr. Schwartz's extensive background in public health and military medicine is highlighted as crucial for restoring scientific rigor at the CDC.

By Katty Kay
Live Nation Monopoly Verdict: No Immediate Price Drops for Concert Tickets

Live Nation Monopoly Verdict: No Immediate Price Drops for Concert Tickets

A federal jury in Manhattan declared Live Nation and Ticketmaster a monopoly, citing anti-competitive practices and consumer overcharging. However, concertgoers shouldn't expect immediate ticket price reductions. The verdict marks a victory for 33 states and Washington, D.C., but the legal battle for specific remedies and penalties is ongoing, with Live Nation planning to appeal and ticket price relief potentially delayed.

By Rageh Omaar
NPR Secures Significant Donations to Boost Digital Innovation and Station Support

NPR Secures Significant Donations to Boost Digital Innovation and Station Support

NPR has received two substantial philanthropic contributions, totaling $113 million, aimed at advancing its digital technology, expanding audience engagement, and reinforcing the sustainability of public radio stations nationwide. These gifts arrive at a critical juncture following the cessation of federal funding for public media, enabling NPR to modernize its infrastructure and enhance its services for a contemporary audience.

By Rageh Omaar
Recipes

Recipes

View more